Qure.ai Technologies Private

ai Technologies Private Limited, based in India, develops AI-driven healthcare solutions that enhance diagnostic accuracy for critical conditions like lung cancer and tuberculosis, streamlining early detection and treatment processes.ai Technologies Private Limited specializes in applying artificial intelligence to healthcare imaging.ai specializes in artificial intelligence-driven healthcare solutions aimed at enhancing the early diagnosis and treatment of critical medical conditions, primarily focusing on lung cancer, tuberculosis (TB), and stroke. Their flagship products include qXR, which analyzes chest X-rays for abnormalities, and AI-enhanced tools for lung nodule management and stroke diagnostics. These technologies integrate seamlessly with both new and existing imaging equipment, facilitating immediate feedback for healthcare providers and expediting patient referrals for further testing. The company serves a diverse client base, including hospitals and imaging centers across multiple regions such as India, the UK, and Lesotho, with partnerships involving organizations like AstraZeneca and Medtronic.ai's initiatives, notably the EDISON Alliance’s 1 Billion Lives Challenge, aim to screen millions of patients by 2025, particularly in underserved communities.58 mn. The company's revenue model is based on business-to-business transactions through subscription agreements and partnerships, enabling healthcare providers to integrate Qure's technology into their systems for real-time imaging data analysis.ai plans to expand its market reach, targeting new regions and sectors to bolster its AI-driven healthcare solutions.

1. Series D

   Sep 25, 2024

   Amount

   $65M

   Investors

   Locked

2. Series D

   May 22, 2024

   Amount

   $1.7M

   Investors

   Locked

3. Series C

   Apr 13, 2022

   Amount

   $39M

   Investors

   Locked

4. Series B

   Feb 24, 2020

   Amount

   $16M

   Investors

   Locked